Skip links

Adzynma (ADAMTS13, recombinant-krhn)

Full Name Adzynma (ADAMTS13, recombinant-krhn)
Drug Adzynma
Manufacturer Takeda Pharmaceuticals U.S.A., Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP)
Disease Congenital thrombotic thrombocytopenic purpura (c-TTP)
Therapeutic Area Hematology
Enrollment Form Link Enrollment Form
Phone Number 800-720-0789
Fax Number 877-251-0709
Product Website